This inventor holds 2 USPTO granted patents. Top assignee: Mallinckrodt, Inc.. Active years: 1978-1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1978-1986
Title: Douglas A. Robinson: Innovator in Pharmaceutical Compositions
Introduction
Douglas A. Robinson is a notable inventor based in Creve Coeur, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance the effectiveness of medications. With a total of 2 patents to his name, Robinson's work is recognized for its innovative approach to drug formulation.
Latest Patents
One of Robinson's latest patents is focused on N-acetyl-p-aminophenol compositions containing partially gelatinized starch. This invention discloses a composition capable of being directly formed into a tablet that exhibits high hardness, short disintegration time, and short dissolution time. The composition includes N-acetyl-p-aminophenol, a pharmaceutically acceptable partially gelatinized starch, a pharmaceutically acceptable lubricant, water, and optionally, an auxiliary binder or disintegrant. Additionally, the patent outlines a method for preparing these essential components and the process of spray drying the slurry.
Career Highlights
Robinson is currently associated with Mallinckrodt, Inc., where he continues to contribute to advancements in pharmaceutical technology. His work is characterized by a commitment to improving the efficacy and delivery of medications, which is crucial in the healthcare industry.
Collaborations
Throughout his career, Robinson has collaborated with esteemed colleagues, including Anil M. Salpekar and Steven R. Freebersyser. These collaborations have further enriched his research and development efforts, leading to innovative solutions in the pharmaceutical sector.
Conclusion
Douglas A. Robinson stands out as an influential inventor in the pharmaceutical field, with a focus on enhancing drug formulations. His contributions, particularly in the area of N-acetyl-p-aminophenol compositions, reflect his dedication to improving patient outcomes through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile